Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the Ministry of Food and Drug Safety for...
Search results for "long-acting"
Forget the 4.5-Hour Window: Why Stroke Care Means Acting Right Now
Stroke remains one of South Korea’s leading causes of death, carrying a high risk of lasting complications or recurrence even after treatment.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Scarlett Johansson’s Nightly Sleep Secret: Can Magnesium Really Transform Your Skin?
Hollywood star Scarlett Johansson, 41, has long drawn attention for her approach to health and wellness.
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Beyond Soccer: How Buenos Aires Comforts and Heals the Soul
(Editor’s note) Travel is not only about taking in beautiful scenery. Sometimes, it drops you into a moment that feels...
Beyond Animal Collagen: Plant-Derived Peptides Emerge as a Clean, Bioactive Alternative
When discussing youthful skin, collagen is almost always part of the conversation. Acting as the body’s internal...